Loading clinical trials...
Loading clinical trials...
Gastric intestinal metaplasia (GIM) is an important premalignant lesion for gastric cancer. Precisely surveillance of patients with GIM may result in early detection and improved prognosis. Though imp...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shandong University
NCT06610266 · Gastric Intestinal Metaplasia
NCT03250091 · Gastric Cancer, Gastric Intestinal Metaplasia, and more
NCT07521618 · Lung Cancer (Suspected or Confirmed), Cryoablation, and more
NCT02794428 · Gastric Cancer, Gastric Intestinal Metaplasia
NCT05288153 · Gastric Intestinal Metaplasia
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions